RECOMBIVAX HB 10 ug/mL

RECOMBIVAX HB 10 ug/mL is a recombinant hepatitis B vaccine designed to prevent hepatitis B infection. This injection is suitable for individuals at risk of exposure to the virus, offering protection through immunization.

RECOMBIVAX HB 10 ug/mL is primarily used for the prevention of hepatitis B virus (HBV) infection. It is administered to individuals who are at risk of exposure to the virus, such as healthcare workers, travelers to regions with high HBV prevalence, and those with chronic liver disease. The vaccine works by stimulating the body's immune response to produce antibodies against the hepatitis B virus, providing long-term protection.

Common effects of RECOMBIVAX HB 10 ug/mL may include mild soreness, redness, or swelling at the injection site. Some individuals may experience temporary fatigue, headache, or low-grade fever following vaccination. These effects are generally mild and resolve within a few days.

RECOMBIVAX HB 10 ug/mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to yeast or any component of the vaccine should avoid it. It is important to inform your healthcare provider about any current medications or health conditions before receiving the vaccine.

RECOMBIVAX HB 10 ug/mL may interact with certain medications that affect the immune system. It is advisable to consult a healthcare provider before taking this vaccine if you are on immunosuppressant therapy or other medications that may impact immune response.